Evidence map›Paper›PMID 26343252›Full record

ReviewPathogens and global health2015

Antimicrobial resistance: a global multifaceted phenomenon.

Francesca Prestinaci, Patrizio Pezzotti, Annalisa Pantosti

3 registry-linked trialsAbstract readReview
In one paragraph

Review in Pathogens and global health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 1,384 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,384citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05100407 completednot on this mapstarted 2022, after this paper: background citation

Evaluation of the Prevalence and Antibiotic Susceptibility Pattern of Multidrug Resistance Bacteria and Its Association With Patients' Predictive Factors

TypeobservationalSponsorKufa UniversityRan2022 to 2022Enrolled400ConditionsMulti-antibiotic Resistance
NCT05762302 narecruitingnot on this mapstarted 2023, after this paper: background citation

A Multicenter Randomized Controlled Trial to Establish the Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

TypeinterventionalSponsorMeMed Diagnostics Ltd.Ran2023 to 2026Enrolled1,316ConditionsLower Respiratory Tract InfectionArmsMeMed BV test
NCT06632132 nacompletednot on this mapstarted 2024, after this paper: background citation

Boosting Knowledge, Attitudes, and Practices: An Experimental Study Evaluating the Effectiveness of mHealth Training on Antimicrobial Resistance for Hemodialysis Nurses

TypeinterventionalSponsorJordan University of Science and TechnologyRan2024 to 2024Enrolled64ConditionsAntimicrobial Resistance in HemodialysisArmsAntimicrobial resistance Training in Hemodialysis Units
3 · Its place in the literature

Who cites it

1,384 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Genomic landscape of 340 virulent Acinetobacter bacteriophages reveals anti-CRISPR-enriched candidates for therapeutic prioritization.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Evaluation of Changes inOpen forum infectious diseases · 2026
    Article
  20. Article

1,324 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francesca PrestinaciDepartment of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità , Rome, Italy.
Patrizio Pezzotti
Annalisa Pantosti

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is one of the most serious global public health threats in this century. The first World Health Organization (WHO) Global report on surveillance of AMR, published in April 2014, collected for the first time data from national and international surveillance networks, showing the extent of this phenomenon in many parts of the world and also the presence of large gaps in the existing surveillance. In this review, we focus on antibacterial resistance (ABR), which represents at the moment the major problem, both for the high rates of resistance observed in bacteria that cause common infections and for the complexity of the consequences of ABR. We describe the health and economic impact of ABR, the principal risk factors for its emergence and, in particular, we illustrate the highlights of four antibiotic-resistant pathogens of global concern - Staphylococcus aureus, Klebsiella pneumoniae, non-typhoidal Salmonella and Mycobacterium tuberculosis - for whom we report resistance data worldwide. Measures to control the emergence and the spread of ABR are presented.

Indexed as

Drug Resistance, BacterialGlobal HealthAnimalsAnti-Bacterial AgentsDrug UtilizationHumansKlebsiella pneumoniaeMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsTuberculosis, Multidrug-ResistantVeterinary MedicineAnti-Bacterial AgentsAntibiotic useAntimicrobial resistanceGlobal surveillanceKlebsiella pneumoniaeMRSAMycobaterium tuberculosisNon-typhoidal SalmonellaVeterinary medicine

Identifiers

PMID26343252
PMCPMC4768623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.